| Overview |
| bsm-62446r |
| MRPL28 Recombinant Antibody |
| WB, IP, Flow-Cyt, ICC/IF |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human MRPL28 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 10573 |
| Q13084 |
| Cytoplasm |
| L28mt; MAAT1; mrpl28; P15. |
| Potentially represents an important therapeutic reagent for HLA-A24 patients. This antigen is recognized by tumor-infiltrating lymphocyte (TIL) 1290 in the context of HLA-A24. |
| Application Dilution |
| WB |
1:300-5000 |
| IP |
1-2ug |
| Flow-Cyt |
1ug/Test |
| ICC/IF |
1:50-100 |
Powered by Bioz